159 related articles for article (PubMed ID: 10073783)
1. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.
Cashin-Hemphill L; Holmvang G; Chan RC; Pitt B; Dinsmore RE; Lees RS
Am J Cardiol; 1999 Jan; 83(1):43-7. PubMed ID: 10073783
[TBL] [Abstract][Full Text] [Related]
2. Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial.
Lees RS; Pitt B; Chan RC; Holmvang G; Dinsmore RE; Campbell LW; Haber HE; Klibaner MI; Cashin-Hemphill L
Am J Cardiol; 1996 Nov; 78(9):1011-6. PubMed ID: 8916480
[TBL] [Abstract][Full Text] [Related]
3. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.
Pitt B; O'Neill B; Feldman R; Ferrari R; Schwartz L; Mudra H; Bass T; Pepine C; Texter M; Haber H; Uprichard A; Cashin-Hemphill L; Lees RS;
Am J Cardiol; 2001 May; 87(9):1058-63. PubMed ID: 11348602
[TBL] [Abstract][Full Text] [Related]
4. The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention.
Texter M; Lees RS; Pitt B; Dinsmore RE; Uprichard AC
Cardiovasc Drugs Ther; 1993 Apr; 7(2):273-82. PubMed ID: 8357782
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
[TBL] [Abstract][Full Text] [Related]
6. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
Schlaifer JD; Mancini GB; O'Neill BJ; Pitt B; Haber HE; Pepine CJ
Cardiovasc Drugs Ther; 1999 May; 13(3):201-9. PubMed ID: 10439882
[TBL] [Abstract][Full Text] [Related]
7. Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention.
Okimoto T; Imazu M; Hayashi Y; Gomyo Y; Sekiguchi Y; Yanagihara K; Shimohara Y; Sumii K; Yamamoto H; Tadehara F; Toyofuku M; Kohno N
Cardiovasc Drugs Ther; 2001 Jul; 15(4):323-9. PubMed ID: 11800416
[TBL] [Abstract][Full Text] [Related]
8. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tsuzuki M; Imai H; Kamiya H; Mabuchi Y; Matsui H; Hayakawa T
Circ J; 2002 Apr; 66(4):311-6. PubMed ID: 11954942
[TBL] [Abstract][Full Text] [Related]
9. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
[TBL] [Abstract][Full Text] [Related]
10. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
[TBL] [Abstract][Full Text] [Related]
11. [Does quinapril improve coronary vasoconstriction in vasospastic angina?].
Anzai H; Saijo T; Nakajima R; Tezuka N; Takagi T; Tsunoda T; Kobayashi N; Nakamura S; Yamaguchi T
J Cardiol; 2000 Dec; 36(6):379-86. PubMed ID: 11190581
[TBL] [Abstract][Full Text] [Related]
12. The Quinapril Ischemic Event Trial (QUIET).
Pitt B
Blood Press Suppl; 1992; 4():11-2. PubMed ID: 1345328
[No Abstract] [Full Text] [Related]
13. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
Oosterga M; Voors AA; Pinto YM; Buikema H; Grandjean JG; Kingma JH; Crijns HJ; van Gilst WH
Am J Cardiol; 2001 Mar; 87(5):542-6. PubMed ID: 11230836
[TBL] [Abstract][Full Text] [Related]
14. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial.
Meurice T; Bauters C; Hermant X; Codron V; VanBelle E; Mc Fadden EP; Lablanche J; Bertrand ME; Amouyel P
Lancet; 2001 Apr; 357(9265):1321-4. PubMed ID: 11343737
[TBL] [Abstract][Full Text] [Related]
15. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
Culy CR; Jarvis B
Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
[TBL] [Abstract][Full Text] [Related]
16. Effect of quinapril on intimal hyperplasia after coronary stenting as assessed by intravascular ultrasound.
Kondo J; Sone T; Tsuboi H; Mukawa H; Kosokabe T; Tsuzuki M; Tomida T; Suzuki T; Kamiya H; Hayashi K; Matsui H; Okumura K
Am J Cardiol; 2001 Feb; 87(4):443-5, A6. PubMed ID: 11179530
[TBL] [Abstract][Full Text] [Related]
17. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
Haleen SJ; Weishaar RE; Overhiser RW; Bousley RF; Keiser JA; Rapundalo SR; Taylor DG
Circ Res; 1991 May; 68(5):1302-12. PubMed ID: 1850330
[TBL] [Abstract][Full Text] [Related]
18. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
19. Long term angiotensin converting enzyme-inhibition in patients after coronary artery bypass grafting reduces levels of soluble intercellular cell adhesion molecule-1.
van Haelst PL; Tervaert JW; van Geel PP; Veeger NJ; Gurné O; Gans RO; van Gilst WH
Eur J Vasc Endovasc Surg; 2003 Oct; 26(4):387-91. PubMed ID: 14512000
[TBL] [Abstract][Full Text] [Related]
20. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
